Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition
Summary: Kinases are important therapeutic targets, and their inhibitors are classified according to their mechanism of action, which range from blocking ATP binding to covalent inhibition. Here, a mechanism of inhibition is highlighted by capturing p21-activated kinase 5 (PAK5) in an intermediate s...
Main Authors: | Heather L. Martin, Amy L. Turner, Julie Higgins, Anna A. Tang, Christian Tiede, Thomas Taylor, Sitthinon Siripanthong, Thomas L. Adams, Iain W. Manfield, Sandra M. Bell, Ewan E. Morrison, Jacquelyn Bond, Chi H. Trinh, Carolyn D. Hurst, Margaret A. Knowles, Richard W. Bayliss, Darren C. Tomlinson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723011968 |
Similar Items
-
Affimer proteins are versatile and renewable affinity reagents
by: Christian Tiede, et al.
Published: (2017-06-01) -
Affimer reagents enable targeted delivery of therapeutic agents and RNA via virus-like particles
by: Sophie E. Roberts, et al.
Published: (2024-08-01) -
Affimer proteins are versatile and renewable affinity reagents.
by: Tiede, C, et al.
Published: (2017) -
Exploiting the Affimer platform against influenza A virus
by: Oliver Debski-Antoniak, et al.
Published: (2024-08-01) -
Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics
by: Hope Adamson, et al.
Published: (2019-12-01)